Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029493	b-hhv6nh	— (—)	346	1022	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

230

34.68

307.65

3.8

1.2

—

Transplanted organ and tissue status

194

157.04

307.65

4.1

1.6

—

L04AD Calcineurin inhibitors

191

99.93

307.65

3.9

4.2

—

Deposits [accretions] on teeth

121

101.52

226.56

5.5

2.5

—

Dental caries

138

36.34

219.99

4.2

1.4

—

ILD medications

244

18.40

200.77

3.6

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

224

18.67

189.39

3.5

1.2

—

Fever of other and unknown origin

143

20.80

180.30

3.1

2.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

215

111

13.21

179.26

3.6

1.5

—

First line medication for Crohn's disease

227

15.52

174.60

3.7

1.5

—

L04AA Selective immunosuppressants

116

27.95

171.90

4.1

2.6

—

ILD medications: azathioprine

71.70

169.85

4.2

1.5

—

Nephropathy related operations

105

34.60

165.96

3.4

3.5

—

Disorders of tooth development and eruption

76.83

165.56

5.3

1.5

—

Dialysis, with operation codes

104

35.36

165.44

3.1

3.7

—

Azathioprine

29.12

138.10

4.2

3.2

—

Dentinal caries

30.08

136.12

3.3

1.3

—

Dentofacial anomalies [including malocclusion]

25.87

130.33

4.6

1.5

—

Kidney transplant status

35.64

130.14

4.0

4.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

22.62

126.12

3.0

3.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

20.62

121.44

3.0

3.5

—

Other diseases of hard tissues of teeth

131

12.56

112.99

4.6

1.4

—

L04AX Other immunosuppressants

124

130

9.57

105.78

4.1

2.1

—

Other problems related to primary support group, including family circumstances

17.74

104.08

5.6

3.6

—

Second line medication for Crohn's disease

126

138

9.16

104.01

4.2

2.1

—

Hypoplasia of dental enamel, including avohilmo

32.60

102.97

5.6

—

Any gastric operation

128

20.76

102.17

3.4

1.4

—

GASTRO-related operations

128

20.76

102.17

3.4

1.4

—

Renal failure

14.44

101.10

3.1

—

Explicit Sepsis

12.88

100.54

3.8

3.4

—

Bacterial infection, other or unspecified

13.64

96.27

3.2

3.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

163

160

7.32

96.03

3.2

2.7

—

Chronic kidney disease

17.19

95.73

3.4

3.5

—

Septicaemia

12.36

95.27

3.9

—

Other septicaemia

13.99

94.98

3.9

3.8

—

Molar incisor enamel hypoplasia

19.36

94.67

5.5

5.0

—

Diseases of liver

15.46

92.17

2.4

2.2

—

Hypoplasia of dental enamel , including avohilmo

18.99

89.24

5.6

5.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

10.61

88.44

5.4

2.6

—

Implicit viral Sepsis

22.23

87.09

3.2

3.3

—

Viral Sepsis

22.23

87.09

3.2

3.3

—

Other bacterial diseases

150

143

7.27

86.35

3.3

2.7

—

Inflammatory bowel disease treatment related agents

172

142

6.89

85.64

3.2

2.4

—

Other diseases of blood and blood-forming organs, wide

16.86

80.61

3.1

3.3

—

Direct fill therapy

13.88

75.79

4.2

—

Anaemias

20.31

74.84

3.7

2.2

—

General symptoms and signs

132

8.08

68.66

2.2

1.9

—

Agranulocytosis

25.81

66.06

3.5

3.9

—

Care involving dialysis

23.34

63.56

4.0

3.8

—

Other viral diseases

129

7.23

63.08

4.5

3.3

—

Implicit Sepsis

103

7.49

61.97

2.6

2.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

109

117

6.78

60.83

2.6

2.5

—

Certain infectious and parasitic diseases

114

8.28

60.31

3.1

1.7

—

Renal tubulo-interstitial diseases

119

167

5.47

55.70

3.1

2.6

—

Implicit bacterial Sepsis

14.33

55.67

2.6

2.8

—

Dialysis

22.16

55.28

4.5

4.9

—

Molar incisor enamel hypoplasia, with caries

91.73

53.48

5.7

3.6

—

Viral infections characterized by skin and mucous membrane lesions

138

6.39

53.40

3.6

3.3

—

Bacterial Sepsis

10.67

52.93

2.7

3.0

—

Cardiovascular diseases (excluding rheumatic etc)

123

125

5.69

52.66

4.0

3.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

107

182

5.35

52.28

3.5

2.6

—

Influenza and pneumonia

140

197

4.68

52.06

2.6

3.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

25.88

51.68

1.9

2.4

—

Any reimbursement code in KELA

12.08

50.23

3.6

1.2

—

100

6.40

49.52

2.4

2.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

100

6.40

49.52

2.4

2.3

—

Gastrointestinal diseases

11.71

49.50

3.8

1.3

—

Antihypertensive medication - note that there are other indications

112

103

5.96

48.66

4.5

2.8

—

Aplastic and other anaemias

8.45

48.51

3.2

3.0

—

Cardiovascular diseases

118

115

5.60

48.38

4.1

3.4

—

Other disorders of gingiva or/and edentulous alveolar ridge

90.81

48.06

4.4

1.0

—

Persons encountering health services for specific procedures and health care

138

195

4.39

46.60

2.9

3.0

—

Secondary hypertension

22.66

46.07

3.4

3.2

—

Examination and observation for other reasons

9.40

45.84

2.6

1.2

—

Diseases of oral cavity, salivary glands and jaws

102

6.24

44.56

4.3

1.3

—

Intestinal infectious diseases

117

205

4.45

43.86

3.3

2.4

—

Extracorporeal dialysis

20.92

43.51

3.9

3.6

—

Viral warts

15.33

43.40

4.2

3.2

—

Cholangitis (primary sclerosing, PSC)

24.15

43.25

4.7

3.2

—

Other viral diseases, not elsewhere classified

6.90

42.97

5.3

3.9

—

Enlarged lymph nodes

21.42

42.71

2.7

3.4

—

Hypertensive diseases (excluding secondary)

6.78

42.50

3.6

2.5

—

Glomerular diseases

9.85

41.81

3.6

3.3

—

Coagulation defects, purpura and other haemorrhagic conditions

9.85

41.81

2.3

4.6

—

Medical observation and evaluation for suspected diseases and conditions

8.40

41.78

2.8

1.3

—

Acute renal failure

15.71

41.71

2.6

2.0

—

Erosion of teeth, including avohilmo

16.15

40.26

5.1

1.1

—

Congenital malformation of biliary tract

34.18

39.36

6.1

3.8

—

Other medical care

8.29

37.88

1.8

3.4

—

Congenital malformations of gallbladder, bile ducts and liver

23.47

37.85

6.1

3.8

—

Nausea and vomiting

7.03

37.62

3.6

3.8

—

Pneumonias (Asthma/COPD co-morbidities)

119

207

3.99

37.40

2.7

3.0

—

Glomerulonephritis

11.61

36.93

3.7

3.9

—

Purpura and other haemorrhagic conditions

11.59

36.92

2.0

5.0

—

Thrombocytopenia, unspecified

20.20

36.34

2.4

5.3

—

Neoplasms

112

135

4.45

36.25

3.8

3.1

—

Malignant neoplasm

103

134

4.57

35.84

3.1

2.8

—

Bronchitis

103

154

4.39

35.73

3.1

2.0

—

All pneumoniae

120

217

3.82

35.63

2.6

3.0

—

Infections, IBD-co-morbidities

12.29

35.31

2.5

4.2

—

Viral and other specified intestinal infections

6.83

35.24

3.8

—

Pneumonia, organism unspecified

104

181

4.16

35.08

2.5

3.2

—

Acute upper respiratory infections of multiple and unspecified sites

137

4.76

34.93

3.6

2.2

—

All influenza

7.99

34.90

3.1

3.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

14.84

34.79

3.1

2.1

—

Heart failure, not strict

117

4.90

33.26

2.6

2.5

—

Other congenital malformations of the digestive system

8.28

33.16

5.2

5.4

—

Other dialysis

21.31

33.01

4.6

3.9

—

Non-follicular lymphoma, hilmo, excluding all cancers

20.97

32.94

1.7

2.7

—

Other anaemias

7.37

32.79

3.2

2.8

—

Other and unspecified anaemias

7.23

31.64

3.3

2.8

—

Nephrotic syndrome

12.71

31.60

3.9

4.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

140

4.19

31.18

3.2

2.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

113

221

3.60

31.13

2.6

3.0

—

Malignant neoplasm, wide definition for exclusion

139

4.17

30.75

3.2

2.8

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

139

4.17

30.75

3.2

2.8

—

Lymphoid leukaemia

15.19

30.54

4.9

5.2

—

Erosion of teeth

+∞

30.47

5.4

0.0

—

Hypertension

129

4.22

29.97

3.3

2.2

—

Anomalies of dental arch relationship, including avohilmo

6.26

29.71

4.6

3.7

—

Hypertensive diseases

130

4.18

29.71

3.3

2.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

22.45

29.62

8.9

5.5

—

Other disorders involving the immune mechanism, not elsewhere classified

22.41

29.61

8.9

5.5

—

Lymphoid leukaemia

13.67

28.83

4.9

—

Other disorders of kidney and ureter

14.51

28.78

3.6

2.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

6.68

28.54

3.2

1.3

—

Oral corticosteroids

121

4.30

28.32

1.6

1.9

—

Other diseases of biliary tract

17.81

28.15

4.5

2.5

—

COPD/asthma related infections

4.50

28.05

2.7

2.3

—

COPD/asthma/ILD related infections

4.50

28.05

2.7

2.3

—

Other heart diseases

4.89

27.99

3.1

3.5

—

Complications of medical and surgical care

143

4.52

27.96

3.2

2.1

—

General examination and investigation of persons without complaint and reported diagnosis

6.69

27.95

4.1

1.3

—

Covid-19 confirmed case

6.58

27.58

2.8

3.1

—

Hypoplasia of dental enamel, prenatal

25.38

26.70

5.3

3.5

—

Complications of surgical and medical care, not elsewhere classified

160

3.86

26.36

3.1

2.1

—

Provisional assignment of new diseases of uncertain etiology

128

4.70

26.28

2.8

2.9

—

Any event in cancer register

139

3.89

26.26

2.9

2.6

—

Codes for special purposes

129

4.66

26.04

2.8

2.9

—

Metabolic disorders

162

3.65

25.65

2.6

—

Other metabolic disorders

11.87

25.60

1.8

3.1

—

Symptoms and signs concerning food and fluid intake

17.56

25.49

4.6

4.3

—

126

3.86

25.13

3.1

2.1

—

Dependence on enabling machines and devices, not elsewhere classified

51.52

24.56

4.0

3.7

—

Other disorders of fluid, electrolyte and acid-base balance

7.82

24.44

2.9

—

Certain disorders involving the immune mechanism

7.09

24.13

6.5

3.2

—

Excessive attrition of teeth

7.65

23.82

4.2

1.5

—

Chronic periodontitis

12.82

23.71

1.3

1.2

—

Other disorders of teeth and supporting structures

10.42

23.55

1.6

1.2

—

Acute upper respiratory infections

149

3.62

23.10

3.4

2.1

—

Missing teeth due to accident, extraction or parodontitis

17.34

22.90

1.2

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

4.56

22.88

3.3

2.1

—

Oxycodone

7.16

22.72

1.5

1.4

—

All influenza (not pneumonia)

8.14

22.60

3.1

3.9

—

Other reaction to severe stress, and adjustment disorders

4.96

22.45

4.2

2.1

—

Mycoses

7.19

22.43

2.0

2.8

—

Bacterial pneumonia (organism specified)

5.09

22.42

2.5

3.0

—

Glomerular disorders in diseases classified elsewhere

14.34

21.92

3.3

3.1

—

Bacterial pneumoniae

5.64

21.66

2.5

3.5

—

Bacterial pneumonia, not elsewhere classified

5.91

21.60

2.3

3.6

—

Zoster [herpes zoster]

10.98

21.54

3.4

1.7

—

Other acute lower respiratory infections

185

3.62

21.46

3.2

3.5

—

Acute tubulo-interstitial nephritis

124

4.15

21.08

3.8

2.9

—

Symptoms and signs involving the digestive system and abdomen

102

161

3.18

20.94

3.2

2.9

—

Reimbursement for rheumatic diseases

141

4.04

20.68

3.7

2.5

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

11.87

20.50

6.0

5.2

—

Lack of expected normal physiological development

10.12

20.49

4.8

4.0

—

Pulmonary heart disease, diseases of pulmonary circulation

7.79

20.38

1.6

2.1

—

Need for other prophylactic measures

12.61

20.33

5.7

5.6

—

10.51

19.99

2.2

3.0

—

Other diseases of liver

10.50

19.99

2.5

2.0

—

Other/unspecified cytomegaloviral diseases

37.06

19.96

2.7

6.4

—

Cytomegaloviral disease

36.78

19.92

2.7

5.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.24

19.63

2.6

2.4

—

Unspecified jaundice

40.50

19.51

3.8

—

Rare circulating lymphoid malignancy

10.68

19.15

6.0

4.9

—

Acute suppurative otitis media

110

4.25

19.06

3.7

3.6

—

Dental caries 2 and operation codes

185

3.27

19.04

4.2

1.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

103

204

2.88

18.97

3.0

2.9

—

Other diseases of the digestive system

5.66

18.93

4.2

3.2

—

Fibrosis and cirrhosis of liver

34.57

18.89

3.3

—

Cytomegalovirus infection, IBD co-morbidity

28.64

18.82

2.7

5.3

—

Non-follicular lymphoma

27.95

18.70

1.7

3.1

—

Care involving use of rehabilitation procedures

165

3.57

18.70

3.4

3.2

—

Endocrine, nutritional and metabolic diseases

150

3.12

18.57

3.5

3.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

12.90

18.55

1.7

3.4

—

Secondary and unspecified malignant neoplasm of lymph nodes

16.08

18.51

1.2

2.3

—

Hypoplasia of dental enamel, prenatal , including avohilmo

10.84

18.29

5.3

4.1

—

Genitourinary diseases

128

3.29

18.26

4.5

3.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

117

4.07

17.81

4.2

4.6

—

Disorders of gallbladder, biliary tract and pancreas

141

3.34

17.75

4.1

1.7

—

Other postsurgical states

14.63

17.62

3.6

2.5

—

Headache

4.61

17.48

3.4

1.8

—

Dental caries 2

189

3.12

17.45

4.2

1.8

—

Otitis media, unspecified

4.95

17.28

3.9

4.6

—

Oedema, not elsewhere classified

9.09

17.19

1.9

2.0

—

Convulsions, not elsewhere classified

6.68

17.10

4.6

2.8

—

Acute pharyngitis

6.34

16.92

3.1

—

Enterocolitis due to Clostridium difficile

15.05

16.75

1.5

3.0

—

Nonsuppurative otitis media

4.24

16.69

4.0

3.6

—

GI-bleeding

5.25

16.50

4.2

3.2

—

Gingivitis and periodontal diseases

4.03

16.43

4.3

1.3

—

Herpesviral [herpes simplex] infections

11.37

16.20

2.9

2.5

—

Secondary uncertain malignant neoplasm

11.37

16.20

1.2

2.2

—

Personal history of other diseases and conditions

8.39

16.16

3.8

1.9

—

Pain, not elsewhere classified

7.87

16.14

2.0

2.5

—

Crossbite

4.57

16.12

5.1

5.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

25.20

16.09

4.6

3.1

—

Infections of the skin and subcutaneous tissue

208

3.12

16.06

4.0

2.8

—

Budesonide

12.34

16.02

1.8

1.7

—

Chronic periapical parodontitis

8.09

15.75

1.3

1.2

—

Crowding of teeth, including avohilmo

4.71

15.72

4.6

5.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

10.65

15.53

1.2

2.9

—

Speech and linguistic disorders, excluding more controls

4.89

15.35

4.9

4.4

—

Nutritional anaemias

105

3.99

15.32

2.7

—

Pulmonary heart disease

7.34

15.23

1.4

1.2

—

Pulmonary embolism

7.34

15.23

1.4

1.2

—

Persons encountering health services in other circumstances, wide

102

204

2.60

15.21

2.8

2.9

—

Disorders resulting from impaired renal tubular function

29.00

15.21

4.4

3.0

—

Diseases of pulp and periapical tissues

5.48

15.21

1.3

1.2

—

Drug-induced neutropenia

28.77

15.18

2.3

1.7

—

Other pulmonary diagnosis

3.98

15.15

3.1

2.4

—

Iron deficiency anaemia

4.09

14.81

2.7

2.8

—

Suppurative and unspecified otitis media

126

3.52

14.58

3.8

3.3

—

Excluding asthma or asthma-COPD overlap

3.91

14.55

3.2

2.4

—

Diseases of the digestive system

131

3.58

14.52

3.6

3.1

—

Other bacterial intestinal infections

8.28

14.49

1.8

3.2

—

Persons with potential health hazards related to communicable diseases

179

3.16

14.47

4.5

3.5

—

Benign neoplasms

111

3.26

14.47

2.7

2.8

—

Heart failure and antihypertensive medication

6.19

14.47

2.5

1.9

—

Disorders of psychological development

112

3.74

14.45

4.5

4.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

131

3.49

14.44

3.8

4.4

—

Viral pneumonia

6.90

14.41

2.4

4.2

—

COPD differential diagnosis

3.85

14.30

3.2

2.4

—

ILD differential diagnosis

3.85

14.30

3.2

2.4

—

Recurring oral aphthae

12.82

14.26

7.1

4.8

—

Acute peritonitis

12.79

14.26

3.2

4.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

22.33

14.20

2.9

3.0

—

Persons encountering health services for examination and investigation

4.59

14.19

3.4

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

8.96

14.04

3.6

2.2

—

Syncope and collapse

6.58

13.78

2.7

2.2

—

Melanocytic naevi of trunk

10.74

13.75

4.3

2.4

—

Other heart diseases, wide

214

2.55

13.48

2.8

3.0

—

Acute bronchitis

121

3.57

13.46

2.3

3.9

—

Other and unspecified drugs and medicaments

13.05

13.37

3.2

4.4

—

Streptococcal septicaemia

13.05

13.37

4.0

7.0

—

DVT of lower extremities and pulmonary embolism

5.18

13.34

1.3

1.2

—

Abnormal findings on examination of blood, without diagnosis

3.89

13.31

3.4

2.8

—

Cardiomyopathy

6.58

13.18

3.2

3.5

—

Oesophageal varices

28.64

12.97

4.3

3.7

—

Cirrhosis of liver, NAS

28.59

12.96

2.8

3.2

—

Congenital malformations of the urinary system

5.63

12.89

3.5

5.9

—

Abdominal and pelvic pain

157

2.66

12.89

3.2

2.7

—

Hypo-osmolality and hyponatraemia

8.09

12.70

3.6

2.4

—

Unspecified kidney failure

32.12

12.56

2.5

4.2

—

Melanocytic naevi of trunk

9.40

12.54

4.3

2.2

—

Diseases of the skin and subcutaneous tissue

157

2.62

12.40

2.6

—

Malaise and fatigue

5.12

12.38

2.9

2.6

—

Congenital malformations, deformations and chromosomal abnormalities

206

2.79

12.23

4.0

2.5

—

Venous thromboembolism

4.14

12.05

1.5

1.4

—

Stomatitis and related lesions

21.34

11.99

6.3

2.0

—

Explicit bacterial Sepsis

10.86

11.95

4.0

5.4

—

Cardiomyopathies, Primary/intrinsic

8.02

11.88

3.3

3.2

—

Cardiomyopathy (excluding other)

8.02

11.88

3.3

3.2

—

Gout, FINNGEN

6.93

11.84

1.4

1.1

—

Chronic periodontitis, complicated

12.04

11.74

1.3

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

187

2.88

11.73

2.8

2.4

—

Speech and linguistic disorders

102

3.60

11.69

5.0

4.8

—

Myeloid leukaemia

30.45

11.67

1.7

6.4

—

Myeloid leukaemia

30.45

11.67

1.7

4.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

9.37

11.65

3.0

4.2

—

Osteopathies and chondropathies

129

3.24

11.56

3.3

2.6

—

Hernia of abdominal wall, postoperative

22.90

11.55

1.7

—

Bacterial intestinal infections, IBD co-morbidities

6.35

11.53

1.8

3.2

—

Candidiasis

8.35

11.48

2.4

2.1

—

Acute sinusitis

109

3.42

11.41

2.8

1.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

7.10

11.41

3.1

2.9

—

Heart failure,strict

4.28

11.39

2.4

2.3

—

Opioids

116

2.85

11.30

2.1

1.6

—

Other and unspecified iron deficiency

3.98

11.16

2.6

3.0

—

Other complications of surgical and medical care, not elsewhere classified

8.78

11.11

2.8

3.1

—

Diseases of peritoneum

8.78

11.11

3.2

3.4

—

Melanocytic naevi

5.01

10.97

4.1

2.5

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

21.65

10.69

1.7

5.9

—

Other and unspecified tonsillitis

3.49

10.61

3.4

2.2

—

Bleeding

176

2.61

10.59

3.8

2.6

—

Haemorrhage from respiratory passages

4.19

10.59

3.9

2.5

—

Cutaneous abscess, furuncle and carbuncle

4.23

10.53

2.9

—

Abnormal findings on diagnostic imaging of lung

4.24

10.51

1.5

1.7

—

Anxiety disorders, excluding more controls

153

2.64

10.31

4.0

1.9

—

Cystic kidney disease

18.97

10.27

3.1

5.3

—

Elevated blood glucose level

8.70

10.23

4.6

—

Disorders of other endocrine glands

178

2.77

10.14

4.1

3.6

—

Polyneuropathies and other disorders of the peripheral nervous system

5.27

10.10

3.6

2.3

—

Certain conditions originating in the perinatal period

3.42

10.08

4.7

4.5

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.51

9.93

6.2

4.4

—

Recurring oral aphthae, including avohilmo

5.44

9.91

5.8

4.2

—

Hypokalaemia

9.25

9.87

2.7

3.8

—

Diffuse large B-cell lymphoma

26.19

9.82

2.8

2.2

—

Heart failure, strict

3.78

9.77

2.4

2.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.77

9.74

2.5

3.0

—

Other and unspecified dermatitis

131

3.06

9.73

2.9

2.8

—

Malignant neoplasm of digestive organs

5.05

9.60

3.8

1.4

—

Asthma (only as main-diagnosis), excluding more controls

3.50

9.54

2.5

—

All-cause Heart Failure

3.79

9.51

2.4

2.2

—

Diseases of middle ear and mastoid

160

2.66

9.45

3.8

2.8

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

4.72

9.42

1.4

2.0

—

Leukaemia of unspecified cell type

+∞

9.42

4.4

0.0

—

Leukaemia of unspecified cell type

+∞

9.42

4.4

0.0

—

Acute laryngitis and tracheitis

5.21

9.41

4.7

3.9

—

Neurotic, stress-related and somatoform disorders

196

2.39

9.35

3.9

2.2

—

Anxiety disorders

196

2.39

9.28

3.9

2.2

—

Intestinal stricture

4.49

9.28

1.9

2.8

—

Childhood asthma (age<16), excluding more controls

6.69

9.27

3.4

5.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

209

2.21

9.26

2.2

3.2

—

Autoimmune diseases excluding thyroid diseases

212

2.20

9.22

2.1

3.2

—

Tooth eruption problems

3.55

9.20

5.1

4.5

—

Asthma-related pneumonia

110

3.18

9.12

2.9

3.9

—

Acute bronchiolitis

3.24

9.07

4.3

5.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

121

2.99

9.00

1.6

2.5

—

Asthma-related pneumonia or sepsis

111

3.15

8.99

2.9

3.9

—

Asthma, hospital admissions 3, pneumonia

111

3.15

8.99

2.9

3.9

—

Non-ischemic cardiomyopathy

4.79

8.95

2.8

2.9

—

Childhood asthma (age<16)

6.36

8.88

3.4

5.4

—

Varicella [chickenpox]

7.27

8.85

3.1

4.2

—

Astigmatism

4.49

8.82

4.7

5.3

—

Asthma (only as main-diagnosis)

3.28

8.78

2.5

2.4

—

Presence of cardiac and vascular implants and grafts

4.82

8.75

1.6

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

148

2.51

8.72

2.7

1.8

—

Cardiomyopathy, other and unspecified

10.03

8.64

2.4

2.9

—

Gout

5.13

8.57

1.4

1.5

—

Other disorders starting during childhood or adolecense, excluding more controls

3.86

8.55

5.4

4.7

—

Cellulitis

4.04

8.50

3.6

3.4

—

Dermatitis

165

2.67

8.43

3.0

2.6

—

Congenital malformations of the circulatory system

117

2.99

8.40

5.1

4.6

—

Asthma, excluding more controls

3.22

8.38

2.4

2.5

—

Chronic lymphocytic leukaemia

+∞

8.34

1.0

0.0

—

Pacemaker

4.86

8.26

2.8

2.7

—

Autoimmune diseases related-to ILD

213

2.35

8.22

2.3

2.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

2.97

8.15

3.8

2.0

—

Other diseases of the respiratory system

4.74

8.10

2.3

3.9

—

Other respiratory disorders and diseases

4.74

8.10

2.3

3.9

—

Abnormalities of breathing

191

2.21

8.09

2.6

2.8

—

Cholecystitis

9.10

8.08

2.0

—

Asthma

3.08

8.08

2.4

—

Undetermined asthma

9.10

8.07

2.8

3.6

—

Undetermined asthma, excluding more controls

9.10

8.07

2.8

3.6

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

4.43

8.06

3.7

1.6

—

Diseases of the eye and adnexa

181

2.16

8.02

3.4

2.9

—

Other and unspecified disorders of white blood cells

22.15

8.02

2.5

3.4

—

Disorders of refraction and accommodation

142

2.74

7.87

4.8

3.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.92

7.86

3.5

1.9

—

Benign neoplasms

177

2.21

7.84

2.6

—

Procreative management

143

2.60

7.74

3.4

3.7

—

Factors influencing health status and contact with health services

6.02

7.72

3.1

1.1

—

Systemic connective tissue disorders

3.86

7.68

3.4

2.3

—

Neurological diseases, wide definition

3.01

7.65

4.7

4.0

—

Paralytic ileus and intestinal obstruction

4.50

7.63

1.9

2.6

—

Dermatitis due to substances taken internally

8.37

7.58

2.1

7.4

—

Disorders of mineral metabolism

8.36

7.58

3.9

3.8

—

Congenital malformations of heart and great arteries

114

2.90

7.54

4.4

4.9

—

Other diseases of intestines

243

2.01

7.54

2.7

3.0

—

Melanocytic naevi

3.66

7.44

4.1

2.2

—

Osteoporosis

4.93

7.41

4.1

2.9

—

Other disorders of white blood cells

13.40

7.38

2.9

3.3

—

Hepatomegaly and splenomegaly, not elsewhere classified

+∞

7.31

3.7

0.0

—

Malnutrition

6.41

7.26

4.7

5.5

—

Disorders of lens

2.74

7.25

2.2

1.8

—

Other diseases of lip and oral mucosa

6.32

7.24

3.3

1.2

—

Other necrotizing vasculopathies

15.78

7.22

4.5

4.9

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

5.04

7.19

4.9

4.8

—

Other noninfective gastroenteritis and colitis

116

2.85

7.17

2.3

4.2

—

Other disorders of skin and subcutaneous tissue

147

2.56

7.14

2.6

2.4

—

Hodgkin lymphoma

20.17

7.14

1.0

5.4

—

Complications of procedures, not elsewhere classified

143

2.54

7.13

2.8

2.0

—

Volume depletion

7.71

7.12

5.0

4.5

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.79

7.10

6.1

5.1

—

Acute pancreatitis

5.66

7.06

4.4

1.4

—

Specific development disorders of scholastic skills

3.91

7.03

5.8

5.5

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

14.34

6.96

8.0

5.8

—

Acute lymphocytic leukaemia, helper endpoint

14.34

6.96

8.0

5.8

—

5-aminosalicylic acid

4.58

6.92

1.3

2.7

—

Tramadol

2.70

6.90

1.8

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

13.79

6.88

1.5

2.9

—

Dermatitis and eczema

246

2.00

6.87

2.7

2.9

—

Non-allergic asthma (mode)

5.14

6.87

4.3

4.1

—

Non-allergic asthma (mode), excluding more controls

5.14

6.87

4.3

4.1

—

Asthma, unspecified (mode), excluding more controls

3.39

6.80

2.0

2.4

—

6-mercaptopurine

16.79

6.75

5.1

2.8

—

Preparatory care for dialysis

16.77

6.75

3.1

3.0

—

Noninfective enteritis and colitis

197

2.33

6.74

1.9

3.6

—

Statin medication

107

2.46

6.74

3.1

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

208

2.29

6.73

4.4

3.3

—

Other cataract

3.56

6.71

3.0

2.1

—

Deep bite

2.93

6.65

4.7

4.6

—

Acute lymphocytic leukaemia

12.74

6.65

8.0

5.2

—

Posteruptive colour changes of dental hard tissues

+∞

6.65

5.0

0.0

—

Acute generalized exanthematous pustulosis

12.29

6.58

2.0

4.4

—

Diseases of the respiratory system

2.86

6.55

3.7

2.6

—

Other congenital malformations of urinary system

15.03

6.48

4.9

8.4

—

Non-invasive ventilation

3.69

6.47

4.7

2.4

—

Drug-induced polyneuropathy

14.74

6.44

5.1

4.9

—

Inflammatory diseases of the central nervous system

6.13

6.43

1.7

3.8

—

Diseases of salivary glands

6.12

6.42

1.7

1.2

—

Other endocrine disorders

3.01

6.40

5.0

5.3

—

Respiratory insufficiency

14.29

6.38

2.3

6.6

—

Symptoms and signs involving the circulatory and respiratory systems

193

1.97

6.33

3.4

2.8

—

Asthma, unspecified (mode)

3.20

6.28

2.0

2.3

—

Aspergillosis

+∞

6.27

1.0

0.0

—

IgA nephropathy (IgA glomerulonephritis)

+∞

6.26

3.3

0.0

—

Autoimmune diseases

216

1.92

6.24

2.3

3.2

—

Urticaria and erythema

138

2.54

6.17

4.3

3.4

—

Used for control exclusion in common control thyroid runs

212

1.91

6.13

2.6

3.2

—

Immunodeficiencies

5.82

6.11

5.0

4.5

—

Other necrotizing vasculopathies (FG)

12.55

6.08

4.7

4.4

—

Depression medications

4.53

5.99

3.0

1.6

—

Viral pneumonia (unknown virus, not influenza)

6.27

5.95

2.5

2.9

—

Preparation and fitting of bite rail to mouth

5.51

5.80

3.4

2.2

—

Other or unspecified ileus, impaction or obstruction

5.50

5.80

1.5

2.4

—

Type of accident

3.00

5.78

3.9

3.0

—

Open bite

3.62

5.76

3.6

5.5

—

Other and unspecified polyneuropathies, also in other diseases

5.01

5.74

2.3

1.2

—

Acute pancreatitis (for exclusion)

4.65

5.73

4.4

1.8

—

AV-block

5.55

5.66

2.8

4.6

—

Left ventricular outflow tract obstruction, narrow definition

3.72

5.64

4.7

5.3

—

Invasive ventilation

5.25

5.52

3.3

3.8

—

TMD related operations

4.49

5.50

3.0

2.4

—

Other symptoms and signs involving the digestive system and abdomen

4.81

5.49

3.5

2.3

—

Cerebrovascular diseases (FINNGEN)

3.58

5.48

3.1

1.9

—

Other and unspecified immunodeficiencies with predominantly antibody defects

16.25

5.43

5.6

5.2

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.77

5.42

5.3

5.0

—

Inflammatory bowel disease

100

2.70

5.41

1.5

3.5

—

Multiple myeloma and malignant plasma cell neoplasms

16.07

5.41

1.8

3.6

—

Multiple myeloma and malignant plasma cell neoplasms

16.07

5.41

1.7

3.6

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

16.07

5.41

1.8

3.6

—

Asthma (mode)

2.63

5.38

2.6

2.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.73

5.36

3.4

5.0

—

Unspecified acute lower respiratory infection

4.12

5.35

2.4

3.6

—

Nail disorders

5.57

5.32

2.5

2.9

—

Other infectious diseases

11.28

5.29

2.1

3.3

—

Alcoholic liver disease

11.27

5.29

1.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

5.22

2.2

0.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

5.22

2.2

0.0

—

Osteonecrosis due to drugs

+∞

5.22

4.6

0.0

—

Chronic hepatitis NAS

+∞

5.22

1.2

0.0

—

Disorders of oesophagus in diseases classified elsewhere

+∞

5.21

1.0

0.0

—

Primary biliary cholangitis (PBC)

+∞

5.21

1.2

0.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.75

5.19

3.8

3.0

—

Hernia

192

1.98

5.14

3.0

2.3

—

Other diseases of pleura

2.84

5.13

2.5

2.7

—

Asthma-related infections

219

2.07

5.10

2.8

3.4

—

Asthma, hospital admission 2, infections

219

2.07

5.10

2.8

3.4

—

Cough

145

2.32

5.10

4.0

3.3

—

Special screening examination for infectious and parasitic diseases

4.01

5.08

2.3

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

13.37

5.08

5.3

3.2

—

Generalized skin eruption due to drugs and medicaments

10.05

5.03

2.2

4.4

—

Pain (limb, back, neck, head abdominally)

146

1.99

5.02

4.1

2.9

—

Tooth agenesis EXCLUDE clefts and syndromes

3.91

4.99

4.1

6.2

—

Parodontitis or operation codes

143

2.16

4.95

1.9

1.5

—

Dental operations

2.57

4.92

3.7

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

3.48

4.88

1.3

3.3

—

193

2.11

4.81

3.0

3.7

—

Sequelae of external causes of morbidity and mortality

3.79

4.80

2.4

2.0

—

Other encephalitis

11.51

4.79

1.4

6.7

—

Artificial opening status

11.47

4.78

3.4

3.7

—

Adjustment and management of implanted device

4.59

4.77

2.4

3.7

—

Phobic anxiety disorders

3.58

4.75

3.7

3.8

—

Congenital malformations of aortic and mitral valves

3.96

4.71

5.0

5.7

—

Continuous positive airway pressure

2.84

4.69

3.8

3.4

—

Valvular heart disease excluding rheumatic fever

2.41

4.66

3.8

3.2

—

Dyspnoea

196

1.95

4.59

2.1

2.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

14.05

4.57

5.9

3.6

—

Cardiac arrhythmias

136

2.09

4.57

2.3

3.0

—

Immunodeficiency with predominantly antibody defects

8.25

4.56

5.9

—

Bacterial, viral and other infectious agents

4.41

4.56

4.9

3.6

—

Hypothyroidism, levothyroxine purchases

3.92

4.53

2.7

2.3

—

Hypothyroidism and >3 levothyroxin purchases

3.92

4.53

2.7

2.3

—

Encephalitis

10.06

4.52

1.4

6.1

—

Hypothyroidism (congenital or acquired)

3.92

4.52

2.7

2.3

—

Dental caries 3 and operation codes, only avohilmo

155

0.29

4.49

7.2

3.9

—

Emotional disorders starting during childhood or adolescence

2.96

4.49

6.2

5.2

—

Inflammatory bowel disease, strict (require KELA)

2.86

4.48

1.5

3.8

—

Leisure time condition

3.41

4.46

4.6

3.2

—

Diaphragmatic hernia

3.27

4.46

2.4

1.4

—

Diseases of the ear and mastoid process

195

1.79

4.45

2.8

2.4

—

IBD patients in KELA-register

2.82

4.38

1.5

3.9

—

Rash and other nonspecific skin eruption

4.24

4.35

4.8

4.2

—

Covid-19 suspected case

2.88

4.32

3.2

3.3

—

Malignant neoplasm of eye, brain and central nervous system

8.93

4.28

1.5

5.2

—

Exclusions for E4_PCOS_BROAD

101

2.48

4.28

3.0

4.7

—

Other diseases of arteries and capillaries

8.91

4.28

1.1

3.6

—

Hyperkinetic disorders, excluding more controls

3.07

4.27

3.6

3.7

—

Codeine

107

2.11

4.26

1.8

1.3

—

2.49

4.22

4.1

5.2

—

Other disorders starting during childhood or adolescence

101

2.47

4.22

5.4

5.2

—

Chronic periodontitis, including avohilmo

144

2.06

4.21

1.9

1.5

—

Diseases of oesophagus, stomach and duodenum

206

1.80

4.19

2.0

2.6

—

Finngen Rheumatological endpoints

176

1.85

4.19

2.3

2.6

—

Specific development disorders of speech and language

2.63

4.18

4.5

5.3

—

Parodontitis

144

2.05

4.16

1.9

1.5

—

Haemolytic anaemias

6.96

4.16

7.3

3.9

—

Polyuria

4.08

4.16

1.3

1.9

—

Diseases of arteries, arterioles and capillaries

2.37

4.14

2.8

1.7

—

Haemorrhagic and haematological disorders of fetus and newborn

2.49

4.01

6.3

5.2

—

Other diseases of pericardium

10.04

4.01

1.1

4.0

—

Other viral hepatitis

6.45

3.98

4.8

2.1

—

Dermatophytosis

6.44

3.98

2.4

2.8

—

Polyarthropathies

150

1.96

3.98

1.7

2.7

—

Presence of other devices

6.43

3.97

3.7

1.7

—

Diverticular disease of intestine

2.39

3.95

1.4

1.3

—

Crohn disease

3.26

3.90

1.5

4.4

—

Valvular operations

3.43

3.90

3.5

4.0

—

Ulcerative colitis

2.68

3.81

1.7

3.5

—

Viral hepatitis

6.01

3.81

4.8

2.1

—

Pruritus

6.01

3.81

4.4

2.7

—

Paroxysmal tachycardia

3.29

3.80

3.2

4.2

—

Urticaria

120

2.25

3.79

4.9

3.7

—

Other pulmonary heart/vessel disease

8.78

3.77

2.1

5.0

—

Noninfectious colitis NAS

3.19

3.77

2.4

4.2

—

Other disorders of bone

3.19

3.77

4.2

2.5

—

Other specified disorders of kidney and ureter

12.05

3.76

2.0

3.2

—

Benign neoplasm: Skin of trunk

12.04

3.76

2.8

3.6

—

Vitamin deficiency, wide

12.03

3.76

5.3

3.0

—

Vitamin deficiency

12.03

3.76

5.3

3.0

—

Other aneurysm

12.03

3.76

5.8

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

12.02

3.76

2.3

5.0

—

Short stature, not elsewhere classified

2.56

3.75

5.7

5.4

—

Psychiatric diseases

193

1.71

3.73

3.2

2.5

—

Mood disorders, excluding more controls

144

1.90

3.71

2.0

1.5

—

3.53

3.70

2.3

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.08

3.67

2.3

1.2

—

Any mental disorder

194

1.70

3.67

3.2

2.5

—

Hydronephrosis

5.63

3.65

3.0

4.2

—

Other and unspecified local infections of skin and subcutaneous tissue

3.85

3.52

6.2

4.2

—

Other local infections of skin and subcutaneous tissue

3.85

3.52

6.2

4.2

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

5.31

3.51

1.7

4.1

—

Viral pneumonia (known virus, not influenza)

6.20

3.50

3.5

4.6

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

6.17

3.50

1.8

4.8

—

Benign neoplasm: Skin of trunk

10.03

3.50

2.8

3.2

—

Emphysema

10.02

3.49

1.7

—

Benign neoplasm of major salivary glands

10.01

3.49

1.5

1.3

—

Other disorders of urethra and urinary system

126

2.02

3.49

2.6

2.7

—

Ulcerative colitis, NAS

3.18

3.49

1.5

4.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

3.17

3.49

1.4

3.4

—

Ulcerative colitis (strict definition, require KELA)

3.17

3.49

1.4

3.4

—

Fitting and adjustment of other devices

3.38

3.48

2.3

2.2

—

Disorders of skin appendages

158

2.03

3.48

2.5

2.8

—

Mucosal proctocolitis

3.55

3.48

1.3

3.2

—

Erysipelas

2.72

3.46

1.6

1.7

—

Infections with a predominantly sexual mode of transmission

2.61

3.45

2.9

1.5

—

COPD (mode)

3.97

3.43

1.0

1.2

—

Other benign neoplasms of skin

2.99

3.40

2.1

2.6

—

Non-rheumatic valve diseases

2.23

3.39

3.5

2.9

—

Conjunctivitis (acute, non atopic)

139

2.08

3.39

2.8

4.1

—

Abnormal serum enzyme levels

2.85

3.37

3.2

2.7

—

Other diseases of intestine

5.01

3.36

4.4

2.6

—

Delayed milestone in childhood

2.33

3.36

5.1

5.5

—

Nonischemic cardiomyopathy

7.02

3.36

2.7

4.3

—

Atrial fibrillation and flutter

2.90

3.35

2.1

1.3

—

Sequelae with surgical and medical care as external cause

3.71

3.35

2.9

2.1

—

Speech therapy

2.83

3.35

2.5

2.4

—

Phlebitis and thrombophlebitis (not including DVT)

3.71

3.35

1.8

1.9

—

2.35

3.35

4.2

5.3

—

Other diseases of urinary system

201

1.68

3.30

2.4

2.7

—

Other congenital malformations of heart

4.87

3.27

3.7

5.6

—

Other diseases of blood and blood-forming organs

8.59

3.26

1.3

2.0

—

ILD, hospital admissions 3, with pneumonia sepsis

8.58

3.26

1.3

2.4

—

ILD, hospital admission 2, with pulmonary infections

8.58

3.26

1.3

5.4

—

Other condition

3.58

3.19

3.3

3.1

—

Crohn's disease of small intestine

5.35

3.19

1.9

4.4

—

Seborrhoeic dermatitis

5.34

3.19

2.8

4.9

—

Excessive, frequent and irregular menstruation

2.40

3.14

2.9

2.1

—

Early onset COPD, excluding more controls

4.50

3.11

1.0

1.1

—

Idiopathic thrombocytopenic purpura

7.53

3.05

4.8

6.1

—

Benign neoplasm of major salivary glands

7.51

3.05

1.5

1.3

—

Irregular menses

2.16

3.00

2.2

1.9

—

Cholelithiasis, broad definition with cholecystitis

112

1.96

3.00

2.5

1.5

—

Other skin changes

4.29

2.99

1.6

3.0

—

Acquired haemolytic anaemia

10.05

2.98

2.8

4.2

—

Hypermetropia

2.75

2.98

5.0

5.2

—

Sequelae of other external causes

10.02

2.98

1.0

2.8

—

Benign neoplasm: Parotid gland

10.01

2.98

1.6

1.4

—

Benign neoplasm: Parotid gland

10.01

2.98

1.6

1.0

—

Retinal vascular occlusion

10.01

2.98

1.6

1.2

—

Retinal vascular disorders

10.01

2.98

1.6

1.2

—

Special screening examination for other diseases and disorders

10.01

2.98

5.0

1.6

—

Aortic aneurysm

4.21

2.94

2.6

1.1

—

Parodontitis and operation codes

146

1.86

2.93

1.9

1.5

—

Pain in throat and chest

153

1.76

2.92

2.7

2.2

—

Distal bite

2.54

2.92

4.8

5.0

—

Other embolism and thrombosis

4.71

2.91

1.5

2.4

—

Dysphagia

3.34

2.90

3.3

1.6

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

4.13

2.89

3.7

6.2

—

Other respiratory diseases principally affecting the interstitium

4.09

2.88

1.2

1.6

—

Intestinal adhesions without obstruction

6.68

2.86

2.5

2.4

—

Persons encountering health services in circumstances related to reproduction

213

1.66

2.86

3.2

3.3

—

Dental caries 1 and operation codes

124

1.78

2.85

3.5

2.2

—

Parasetamol

131

1.75

2.85

3.5

2.3

—

Ischaemic heart disease, wide definition

1.98

2.84

1.8

1.2

—

Anti-inflammatory and antirheumatic products, non-steroids

108

0.33

2.83

5.3

4.2

—

Dental pulpitis 2

102

1.86

2.81

3.3

2.5

—

Congenital absence, atresia and stenosis of large intestine

9.03

2.81

3.6

6.2

—

Symptoms and signs involving the urinary system

170

1.77

2.80

2.7

2.4

—

Contact with and exposure to communicable diseases

157

1.90

2.80

4.3

3.3

—

Disorders in reading

4.49

2.80

7.0

6.3

—

DVT of lower extremities

4.45

2.79

1.0

1.2

—

Aortic valve malfunction, age under 60 years

3.23

2.77

2.9

4.2

—

Dental caries 1, only avohilmo

185

0.44

2.75

3.0

3.2

—

Congenital malformations of cardiac septa

2.17

2.74

4.6

5.1

—

COPD-related respiratory insufficiency

5.01

2.72

1.0

1.1

—

Methotrexate

5.00

2.72

1.0

1.6

—

Ulcer of lower limb, not elsewhere classified

5.00

2.72

1.0

2.2

—

Benign neoplasm: Colon

2.68

2.70

1.1

1.5

—

Other and unspecified injuries of ankle and foot

6.02

2.70

2.3

3.0

—

Ingrowing nail

6.01

2.70

3.2

3.3

—

Diseases of the musculoskeletal system and connective tissue

154

1.66

2.69

3.8

3.6

—

Atrophic disorders of skin

4.22

2.67

6.0

2.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

5.16

2.64

1.3

1.7

—

Skin changes due to chronic exposure to nonionizing radiation

3.15

2.64

2.6

1.2

—

Senile cataract

2.13

2.64

1.2

—

Depression

206

1.64

2.63

2.0

2.3

—

Dental caries, including avohilmo

112

1.78

2.62

3.7

2.4

—

Dental caries 1

112

1.78

2.62

3.7

2.4

—

Embedded and impacted teeth

2.06

2.60

3.1

3.8

—

Other diseases of anus and rectum

2.54

2.60

2.6

—

Migraine

149

1.83

2.59

3.3

3.1

—

Benign neoplasm of colon, rectum, anus and anal canal

2.38

2.58

1.2

1.4

—

Dental caries 3, only avohilmo

201

0.48

2.58

4.5

3.2

—

Disorders of calcium metabolism

7.15

2.55

2.6

5.4

—

Benign neoplasm: salivary glands, exclude unknown (D119)

7.15

2.55

1.6

1.0

—

Other coagulation defects

5.46

2.54

2.8

3.6

—

Congenital malformations of great veins

4.57

2.50

3.9

4.6

—

Hypertension, essential

103

1.83

2.49

1.7

1.5

—

ILD, hospital admissions 1, main diag only

4.38

2.47

1.3

1.7

—

Abnormal findings on diagnostic imaging of other body structures

4.38

2.47

1.0

2.6

—

Ischemic heart diseases

105

1.85

2.47

1.8

1.3

—

Unspecified haematuria

2.28

2.45

4.1

2.3

—

Neonatal jaundice from other and unspecified causes

2.22

2.44

7.6

5.3

—

Chondropathies

2.94

2.41

4.3

2.4

—

Dental pulpitis 2, only avohilmo

104

1.77

2.41

3.4

2.5

—

Motor disorders, excluding more controls

2.56

2.40

4.5

5.2

—

Chronic pancreatitis

5.00

2.40

3.0

1.2

—

Impetigo

3.34

2.39

4.2

5.4

—

Complex cardiac defects

4.22

2.38

4.6

5.7

—

Attention to artificial openings

6.27

2.37

4.4

4.3

—

Other and unspecified coagulation defects

6.26

2.37

1.8

4.0

—

Cerebral cysts

6.26

2.37

4.8

3.8

—

Opening and dilatation of root channel of tooth

6.26

2.37

1.2

5.1

—

Viral infections of the central nervous system

6.26

2.37

4.2

2.4

—

Intracerebral haemorrhage

6.25

2.37

3.6

1.6

—

Disorders of speech understanding and production

2.35

2.36

4.3

5.1

—

Hard cardiovascular diseases

119

1.78

2.36

2.0

1.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.64

2.36

1.6

2.3

—

Collagenous colitis

4.12

2.36

1.0

3.5

—

Parodontitis or/and operation codes

106

1.80

2.32

2.0

1.7

—

Chronic gastritis

2.86

2.30

1.5

—

4.64

2.27

6.8

4.8

—

Fissure and fistula of anal and rectal regions

2.68

2.27

3.1

2.0

—

Impacted maxillary molar

4.62

2.27

2.7

4.2

—

Other Crohn's disease

4.62

2.27

1.2

3.4

—

Biological medication for rheuma

2.56

2.26

1.4

3.2

—

Colonic or urogenital fistula

2.55

2.26

3.7

2.0

—

KRA_PSY_EATING, excluding more controls

3.47

2.26

2.9

3.0

—

Other/unspecified synovitis and tenosynovitis

3.89

2.25

1.7

1.8

—

ILD, hospital admissions

3.89

2.25

1.3

1.7

—

Interstitial lung disease endpoints

3.89

2.25

1.3

1.7

—

Interstitial lung disease

3.89

2.25

1.3

1.7

—

Other interstitial pulmonary diseases

3.89

2.25

1.3

1.7

—

Benign neoplasm of other and ill-defined parts of digestive system

3.89

2.25

1.1

1.7

—

Benign neoplasm: Transverse colon

5.56

2.21

1.0

1.2

—

Benign neoplasm: Transverse colon

5.56

2.21

1.0

1.2

—

Cholelithiasis

108

1.82

2.20

2.4

1.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.78

2.20

2.9

1.6

—

Neurological diseases

217

1.49

2.18

3.3

3.2

—

Diabetic nephropathy

3.29

2.14

2.9

1.5

—

Heart failure and bmi 25plus

2.87

2.13

1.6

1.1

—

Mood [affective] disorders

209

1.54

2.10

2.0

2.3

—

COPD, hospital admission 2, with asthma infections

2.75

2.09

1.0

1.5

—

Mood disorders

209

1.54

2.09

2.0

2.3

—

Viral agents as the cause of diseases classified to other chapters

5.02

2.07

5.0

4.3

—

Other ulcerative colitis

5.01

2.07

1.4

3.4

—

Benign neoplasm: Ascending colon

5.00

2.07

1.4

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

170

1.59

2.06

2.4

3.4

—

Codeine or tramadol medication

158

1.58

2.06

1.7

1.3

—

Disturbance of activity and attention

2.08

2.05

3.6

4.5

—

Noninflammatory disorders of female genital tract

1.98

2.04

3.5

2.2

—

Chronic sinusitis

103

1.94

2.04

3.3

1.8

—

Erectile dysfunction

4.01

2.04

4.5

2.1

—

Diplopia

4.00

2.04

2.0

3.5

—

Gout, unspecified

4.00

2.04

2.2

1.0

—

Lung diseases due to external agents

4.00

2.04

2.2

2.6

—

Weight loss

3.08

2.01

6.3

4.9

—

Dorsalgia

177

1.53

2.01

1.8

2.2

—

Temporomandibular joint disorders

3.08

2.01

1.3

1.8

—

Coronary revascularization (ANGIO or CABG)

2.23

2.00

1.5

1.3

—

Other gastritis (incl. Duodenitis)

2.81

2.00

1.2

2.0

—

Presence of other functional implants

2.36

1.97

2.7

1.2

—

Fracture of skull and facial bones

2.28

1.97

2.3

3.1

—

Other disorders of veins

2.28

1.97

1.5

1.1

—

Adalimumab

3.34

1.96

1.0

3.1

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.28

1.96

1.1

1.3

—

Bronchiectasis

4.55

1.94

2.8

4.3

—

Seronegative rheumatoid arthritis

4.55

1.94

1.0

1.1

—

Hordeolum and other deep inflammation of eyelid

3.76

1.93

4.3

4.2

—

Acute lymphadenitis

3.76

1.93

5.5

4.7

—

Otitis externa, unspecified

2.73

1.93

6.8

3.6

—

Recurrent or chronic depression

1.87

1.92

2.0

1.5

—

Other systemic involvement of connective tissue (FG)

2.71

1.91

2.1

—

Major coronary heart disease event

1.82

1.90

1.5

1.4

—

Other and unspecified urticaria

2.05

1.90

3.3

4.2

—

Emergency coronary revascularization (for ACS)

2.16

1.89

1.5

1.3

—

Dental pulpitis 1, only avohilmo

236

0.60

1.88

1.3

2.9

—

Pain associated with micturition

3.18

1.88

1.9

3.2

—

Cerebral palsy and other paralytic syndromes

2.65

1.86

2.7

4.3

—

All anxiety disorders

157

1.64

1.86

3.7

2.2

—

Anterior Iridocyclitis

2.65

1.86

1.2

2.5

—

Infectious mononucleosis

2.86

1.86

3.4

3.6

—

Atrial septal defect

2.15

1.85

4.4

4.9

—

Other arthritis (FG)

2.03

1.85

1.7

2.8

—

Bell's palsy

3.53

1.83

5.0

1.8

—

COPD

2.23

1.82

1.3

1.4

—

Post-traumatic stress disorder

4.17

1.82

2.0

3.9

—

Otitis externa

2.12

1.81

5.5

3.4

—

Other disorders of lacrimal gland

2.12

1.81

5.9

2.0

—

Cystitis

162

1.55

1.80

2.3

2.7

—

Early onset COPD

2.57

1.80

1.0

1.4

—

Benign neoplasm of other and ill-defined parts of digestive system

3.05

1.80

1.1

1.6

—

Eating disorders

2.57

1.79

2.7

3.7

—

Benign lipomatous neoplasm

2.76

1.79

1.4

2.2

—

Benign neoplasm: Colon

2.11

1.78

1.1

1.2

—

Heart failure and coronary heart disease

2.84

1.78

1.8

1.4

—

Myopia

2.34

1.77

5.0

4.2

—

Hypothyroidism, drug reimbursement

3.58

1.77

2.8

2.4

—

Diabetic nephropathy, excluding more controls

2.78

1.77

2.9

1.5

—

Other benign neoplasms of skin

2.09

1.75

2.1

2.2

—

Polycystic ovarian syndrome, consortium definition

1.71

1.75

2.0

1.9

—

Pain in joint

110

1.69

1.75

2.0

2.7

—

Other disorders of adrenal gland

3.34

1.74

2.7

4.3

—

Haemangioma, any site

3.34

1.74

3.2

3.7

—

Acute and subacute iridocyclitis

2.67

1.72

1.1

2.3

—

Radiculopathy

2.92

1.72

1.7

1.4

—

Impacted teeth

1.93

1.72

3.3

3.8

—

Congenital deformities of feet

3.86

1.71

2.8

6.5

—

Gastroduodenal ulcer

2.66

1.71

2.9

1.3

—

Benign neoplasm: Ascending colon

3.85

1.71

1.4

1.2

—

Benign neoplasm: Rectum

3.85

1.71

1.2

—

Disturbances of skin sensation

2.29

1.70

2.4

2.0

—

Dental pulpitis 3, only avohilmo

109

0.40

1.68

1.7

4.9

—

Actinic keratosis

2.62

1.67

3.0

1.2

—

Use of hypnotics and sedatives

180

1.48

1.65

2.0

2.2

—

Umbilical hernia

2.10

1.65

1.8

2.0

—

Parodontitis, operation under 40 years and operation codes

2.80

1.65

5.0

2.8

—

Hypopituitarism

2.25

1.63

4.2

4.8

—

Inguinal hernia

120

1.63

1.62

3.6

2.4

—

Asthma, hospital admissions , main diagnosis only

284

1.45

1.62

2.8

2.9

—

Allergic asthma (mode), excluding more controls

2.53

1.61

3.8

2.8

—

Other specified/unspecified hearing loss

3.58

1.61

1.0

4.0

—

Benign neoplasm: Rectum, anus and anal canal

3.57

1.61

1.2

—

Migraine without aura and triptan purchases

2.33

1.60

4.9

2.7

—

Specific developmental disorder of motor function

2.08

1.59

4.5

6.1

—

Migraine with aura

2.00

1.58

2.9

—

Hernia of abdominal wall

106

1.79

1.58

1.9

2.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

3.00

1.58

1.0

2.1

—

Parodontitis, under 40 years, or operation codes

2.69

1.58

5.0

2.8

—

Seropositive rheumatoid arthritis

2.69

1.57

1.6

1.1

—

Disorders of parathyroid gland

2.66

1.55

3.0

1.6

—

Other anxiety disorders

114

1.71

1.55

4.0

2.3

—

Propionic acid derivatives

106

0.47

1.54

4.0

4.2

—

Eating disorder

2.42

1.53

2.9

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

1.85

1.53

1.2

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.34

1.52

1.8

3.5

—

Crohn disease (strict definition, require KELA)

3.34

1.52

1.8

3.5

—

Eustachian salpingitis and obstruction

3.34

1.52

5.2

2.8

—

Biguanides

153

0.52

1.52

1.4

—

Female infertility

2.18

1.52

1.5

1.4

—

Other disorders of optic [2nd] nerve and visual pathways

2.86

1.50

2.7

4.8

—

Other and unspecified injuries of lower leg

2.86

1.50

2.3

3.7

—

Fracture of lumbar spine and pelvis

2.85

1.50

2.5

1.7

—

Respiratory and cardiovascular disorders specific to the perinatal period

103

1.75

1.49

4.9

5.3

—

Exposure to unspecified factor

289

1.40

1.49

3.4

2.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2.22

1.48

1.0

1.3

—

Motor disorders

2.01

1.48

4.5

5.9

—

Other systemic involvement of connective tissue

2.43

1.47

2.1

2.0

—

Coronary atherosclerosis

1.74

1.47

1.1

—

Tumor necrosis factor alpha inhibitors

2.22

1.46

1.5

3.3

—

Iridocyclitis

2.22

1.46

1.2

3.0

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2.30

1.46

1.0

1.2

—

Conduction disorders

2.08

1.46

2.7

4.5

—

Generalized anxiety disorder

2.37

1.45

2.7

2.3

—

Disorders of optic nerve and visual pathways

2.50

1.45

2.4

4.0

—

Other disorders of glucose regulation and pancreatic internal secretion

2.50

1.45

3.6

5.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

132

1.67

1.45

4.4

3.4

—

Tonsillectomy and adenotomy

208

1.44

3.8

3.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.13

1.44

1.8

3.4

—

Plantar fascial fibromatosis

3.13

1.44

2.2

1.5

—

Crohn's disease NAS

2.73

1.43

2.2

6.1

—

Exposure to other and unspecified inanimate mechanical forces

2.73

1.43

2.8

4.5

—

Haemangioma and lymphangioma, any site

2.73

1.43

3.2

3.5

—

Thyroiditis, ILD-related definition

2.73

1.43

1.3

3.4

—

Seborrhoeic keratosis

2.73

1.43

1.5

1.2

—

Disorders of thyroid, IBD co-morbidities

2.55

1.43

1.4

3.8

—

COPD, hospital admissions 1, only main diagnosis

2.32

1.43

1.0

1.3

—

Menorrhagia

1.99

1.40

1.9

1.8

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.18

1.39

3.8

2.1

—

Follicular cysts of skin and subcutaneous tissue

2.42

1.39

1.0

1.9

—

Other specified/unspecified arthritis

1.89

1.38

1.6

3.2

—

Coeliac disease

2.20

1.36

1.4

5.0

—

Other (seronegative) rheumatoid arthritis, wide

2.61

1.36

1.0

1.5

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

2.94

1.36

2.0

3.6

—

Other symptoms and signs involving the urinary system

2.94

1.36

1.4

2.4

—

Misadventures to patients during surgical and medical care

2.94

1.36

3.2

2.6

—

Artrosis, including avohilmo

138

0.56

1.35

1.2

1.4

—

Dental pulpitis 4, only avohilmo

234

0.67

1.34

1.3

3.0

—

Contraceptive management

1.65

1.33

2.5

1.5

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2.84

1.31

2.8

1.2

—

Haemangioma, any site

2.50

1.30

3.2

3.7

—

Diagnoses used for exclusion with ILD

2.09

1.30

1.8

2.3

—

Allergic asthma (mode)

2.38

1.29

3.8

2.8

—

Mixed conductive and sensorineural hearing loss

2.78

1.28

1.2

2.2

—

Episodal and paroxysmal disorders

261

1.32

1.27

2.4

3.1

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2.15

1.27

1.0

1.2

—

Other hearing loss

2.31

1.27

1.1

2.4

—

Hyperparathyroidism

2.75

1.27

1.2

1.3

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.29

1.26

1.4

3.3

—

Anxiety (asthma-related co-morbidities)

171

1.48

1.26

3.7

2.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

171

1.51

1.25

2.8

3.0

—

COPD related to multimorbidity

2.05

1.25

1.0

1.4

—

Cardiac murmurs and other cardiac sounds

1.82

1.25

4.9

4.6

—

Congenital malformations of cardiac chambers and connections

2.44

1.25

5.0

6.3

—

Other arrhythmias

123

1.56

1.24

1.6

2.5

—

Gout, idiopatic and unspecified

2.40

1.24

2.2

1.1

—

Nasal polyp

2.22

1.24

2.5

1.3

—

Retinal detachments and breaks

2.00

1.23

2.1

1.3

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.64

1.22

9.8

7.9

—

Conductive hearing loss, unspecified

2.63

1.21

7.2

5.1

—

Abnormal results of function studies

2.63

1.21

2.0

5.4

—

Perforation of tympanic membrane

2.63

1.21

3.8

3.5

—

Injuries to the ankle and foot

254

1.40

1.20

3.8

2.7

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.95

1.20

1.4

1.7

—

Other noninflammatory disorders of uterus, except cervix

0.00

1.19

0.0

1.2

—

Injuries to the thorax

101

1.68

1.19

1.5

2.0

—

Dementia, including avohilmo

0.00

1.18

0.0

1.4

—

Hypoglycaemia, other or unspecified

2.31

1.18

4.0

5.0

—

Amblyopia ex anopsia

2.11

1.18

4.8

6.1

—

Congenital malformations of great arteries

1.84

1.18

4.9

5.3

—

Fall involving playground equipment

0.00

1.16

0.0

5.8

—

Dental caries 2 and operation codes, only avohilmo

231

0.67

1.16

3.7

2.9

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

146

1.54

1.16

2.3

2.0

—

Other chronic obstructive pulmonary disease

1.95

1.15

1.0

1.3

—

COPD, hospital admissions

1.94

1.15

1.0

1.4

—

Abscess of anal and rectal regions

2.50

1.15

2.6

3.9

—

Benign neoplasm: Rectum

2.50

1.15

1.2

—

Orchitis and epididymitis

2.50

1.15

2.6

2.5

—

Benign paroxysmal vertigo

2.05

1.15

1.0

1.6

—

Functional dyspepsia

2.05

1.15

1.3

1.7

—

Hyperlipidaemia, other/unspecified

2.05

1.14

1.8

1.7

—

Other obstetric conditions, not elsewhere classified

1.90

1.13

1.4

1.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.38

1.13

1.0

1.4

—

Conductive and sensorineural hearing loss

148

1.45

1.13

3.7

2.6

—

Vocal cord dysfunction

2.32

1.12

2.7

2.5

—

Atopic dermatitis, strict definition with reimbursement

154

1.51

1.11

2.8

3.9

—

Other antidepressants

159

1.38

1.11

1.5

1.8

—

Hydrocele

2.26

1.10

3.9

3.4

—

Paracetamol of NSAID medication

0.52

1.10

10.0

4.3

—

Other eating disorders

2.38

1.09

3.2

4.8

—

Foreign body in respiratory tract

2.38

1.09

4.2

3.7

—

Visual disturbances and blindness

160

1.50

1.08

2.9

3.1

—

Ventral hernia

2.19

1.08

2.1

1.7

—

Angina pectoris

1.69

1.08

1.9

1.1

—

Epilepsy

144

1.52

1.07

2.4

4.0

—

Embedded teeth, including avohilmo

2.12

1.05

3.0

4.5

—

Disorders of sclera, cornea, iris and ciliary body

145

1.52

1.05

2.0

2.4

—

Female infertility, cervigal, vaginal, other or unspecified origin

1.97

1.05

1.3

1.4

—

Coronary angioplasty

1.97

1.04

1.7

1.4

—

Other disorders of ear

213

1.34

1.04

3.2

2.7

—

COPD, early/later onset

1.86

1.03

1.0

1.4

—

Social phobias

2.27

1.03

3.4

—

Chalazion

2.27

1.03

2.2

2.9

—

Benign neoplasm: Rectum, anus and anal canal

2.27

1.03

1.2

—

Asthma (diagnoses ohter than nonallergic)

283

1.33

1.02

2.7

2.9

—

Persistent mood disorders

2.06

1.02

1.6

2.3

—

Fibroblastic disorders

2.06

1.02

2.1

1.3

—

Mandibular retrognathia

1.91

1.01

6.9

4.7

—

Gastro-oesophageal reflux disease

166

1.44

1.00

2.1

2.7

—

Rheumatoid arthritis

1.89

1.00

1.4

1.5

—

Dementia

0.00

1.00

0.0

1.5

—

Any dementia, excluding more controls

0.00

1.00

0.0

1.4

—

Visual disturbances

147

1.50

1.00

2.9

3.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.00

1.00

1.6

1.1

—

Diseases of external ear

107

1.59

0.99

5.4

3.2

—

Abnormal weight loss

2.18

0.98

2.6

4.6

—

Superficial injury of thorax

2.17

0.98

1.2

2.2

—

Nontraumatic intracranial haemmorrhage

2.17

0.98

3.6

1.8

—

Complications of labour and delivery

0.54

0.97

2.0

1.4

—

Gonarthrosis

0.54

0.97

1.1

1.3

—

Other/unspecified seropositive rheumatoid arthritis

1.95

0.97

1.6

1.1

—

Seropositive rheumatoid arthritis, wide

1.95

0.97

1.6

1.1

—

Sulfasalazine

1.94

0.97

1.0

1.2

—

Acne

1.80

0.96

4.0

4.3

—

Ovarian cyst

1.75

0.96

2.6

1.6

—

Other/unspecified dorsalgia

1.66

0.96

3.1

2.2

—

Allergic conjunctivitis

195

0.61

0.95

3.7

2.7

—

Other retinal disorders

1.55

0.94

2.0

2.3

—

Other specific joint derangements/joint disorders

178

1.36

0.93

2.0

2.9

—

Disorders of lacrimal system

1.61

0.93

5.7

2.6

—

Maternal care for known or suspected fetal abnormality and damage

2.22

0.93

1.2

1.4

—

Diseases of inner ear

1.61

0.93

1.3

1.5

—

Disorders of breast

1.62

0.93

1.9

1.7

—

Other and unspecified effects of external causes

109

1.56

0.93

2.3

3.7

—

Sciatica+with lumbago

111

1.54

0.93

1.3

1.4

—

Dizziness and giddiness

155

1.41

0.92

2.4

2.1

—

Haemangioma and lymphangioma, any site

2.14

0.91

3.2

3.5

—

Spondylopathies

120

0.61

0.91

1.3

1.8

—

Disorders of conjunctiva

276

1.30

0.90

2.6

3.1

—

Dental pulpitis 3

114

0.57

0.90

2.1

4.7

—

Abnormalities of heart beat

1.70

0.90

2.5

2.1

—

Dental operations, only avohilmo

126

0.65

0.89

1.8

2.8

—

Coronary artery bypass grafting

2.08

0.89

1.2

1.1

—

Diabetes, varying definitions

212

1.30

0.88

2.5

2.7

—

Other disorders of eye and adnexa

1.91

0.88

9.0

4.1

—

Benign lipomatous neoplasm

1.91

0.88

1.4

2.0

—

Open wound of wrist and hand

151

0.59

0.88

2.0

2.5

—

Pain in limb

220

1.31

0.88

3.7

2.8

—

Adverse effects, not elsewhere classified

1.65

0.87

2.7

3.8

—

Atopic dermatitis

194

1.36

0.87

2.6

3.3

—

Varicose veins

1.60

0.87

1.3

1.2

—

Allergic urticaria

2.00

0.87

11.3

5.6

—

Primary coxarthrosis, bilateral

2.00

0.87

1.3

1.2

—

Coxarthrosis [arthrosis of hip](FG)

1.60

0.86

1.3

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.50

0.85

1.2

1.7

—

Bacterial sepsis of newborn

1.96

0.85

4.3

6.3

—

Lower back pain or/and sciatica

188

1.33

0.84

1.2

2.0

—

Disorders of puberty, all

1.94

0.84

4.2

6.9

—

Conjunctivitis

268

1.30

0.84

2.7

3.2

—

Migraine without aura

1.63

0.84

4.6

3.7

—

Insulin medication

174

1.38

0.84

2.8

3.0

—

Acute nasopharyngitis (common cold)

1.92

0.84

1.0

2.3

—

Septal defects

102

1.54

0.83

4.5

5.2

—

Alcohol use disorder, Swedish definition

127

1.46

0.83

1.7

1.8

—

Hyperkinetic disorders

111

1.51

0.83

3.6

4.7

—

Arthropathies

209

1.27

0.83

2.2

3.2

—

Disorders of lipoprotein metabolism and other lipidaemias

106

1.42

0.83

1.3

1.8

—

Low back pain

157

1.37

0.82

1.1

2.0

—

Appendectomy

173

1.39

0.82

1.1

1.9

—

Juvenile arthritis (FINNGEN)

1.88

0.81

3.0

6.4

—

Somatoform disorder

1.88

0.81

1.5

2.1

—

Degenerative diseases of the nervous system

0.00

0.81

0.0

1.2

—

Any dementia

0.00

0.80

0.0

1.5

—

Disorders of eyelid, lacrimal system and orbit

195

1.33

0.80

4.3

2.3

—

Other infections specific to the perinatal period

0.00

0.79

0.0

6.0

—

Intermittent heterotropia

1.73

0.79

5.3

5.1

—

Early lumbar disc prolapse, operated

0.00

0.79

0.0

1.8

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

114

1.49

0.79

3.2

3.5

—

Disorders of choroid and retina

131

1.39

0.78

1.8

1.9

—

Fracture of rib(s), sternum and thoracic spine

1.67

0.78

1.9

1.6

—

Strabismus

139

1.44

0.78

5.2

3.7

—

147

1.40

0.78

2.5

2.0

—

Cerebrovascular diseases

111

1.42

0.77

2.9

1.8

—

Congenital malformations and deformations of the musculoskeletal system

106

1.50

0.77

4.1

4.6

—

Insulin, fast-acting

123

1.46

0.77

3.3

3.7

—

Persons encountering health services in other circumstances

115

1.48

0.76

2.3

3.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.72

0.76

1.0

1.3

—

Sensorineural hearing loss

133

1.37

0.75

3.1

2.6

—

Calculus of kidney and ureter

1.70

0.75

2.3

1.6

—

External causes of morbidity and mortality

151

1.29

0.75

3.9

2.7

—

Colorectal cancer

2.08

0.74

2.8

1.2

—

Other dorsopathies, not elsewhere classified

183

1.27

0.74

2.1

2.3

—

Mixed specific developmental disorders

1.60

0.73

3.7

5.8

—

Diabetes mellitus

213

1.26

0.73

2.8

2.7

—

Alcohol dependence

1.64

0.73

1.2

1.3

—

Respiratory distress of newborn

1.54

0.73

5.1

5.4

—

Gonarthrosis,primary

124

0.66

0.73

1.2

1.3

—

Intracranial injury

223

0.69

0.72

4.2

3.1

—

Parodontitis, under 40 years and operation codes

2.00

0.72

6.2

2.8

—

Salpingitis and oophoritis

2.00

0.72

2.0

1.2

—

Coxarthrosis

1.52

0.72

1.3

1.1

—

Allergic colitis

1.67

0.72

3.8

5.1

—

Psoriasis

1.67

0.72

3.0

2.1

—

Rheumatoid arthritis, including avohilmo

1.67

0.72

1.4

1.3

—

Fracture of femur

1.78

0.72

3.4

2.8

—

Heterophoria

1.75

0.71

5.0

5.5

—

Leiomyoma of uterus

1.52

0.71

1.3

—

Other nutritional deficiencies

198

1.33

0.70

2.5

2.4

—

Congenital malformations of the nervous system

1.93

0.70

1.6

5.5

—

Other inflammation of eyelid

1.92

0.70

9.2

3.1

—

Use of pramipexole

1.92

0.70

1.2

1.3

—

Chronic lower respiratory diseases

277

1.21

0.70

2.6

2.9

—

Other congenital malformations of tongue, mouth and pharynx

1.92

0.70

4.2

5.2

—

Coxibs

0.52

0.70

1.2

1.9

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.58

0.70

4.8

5.0

—

Open wound of lower leg

1.71

0.70

2.7

4.2

—

Insulin, fast-acting or short human

126

1.43

0.69

3.3

3.7

—

Congenital malformations of pulmonary and tricuspid valves

1.87

0.69

4.4

6.1

—

Spontaneous abortion

0.54

0.68

2.0

1.2

—

Focal epilepsy, strict definition

1.53

0.68

2.5

4.5

—

Parodontitis, under 40 years

1.85

0.68

6.2

2.7

—

Injury of muscle and tendon at wrist and hand level

1.85

0.68

1.0

2.1

—

Urolithiasis

1.53

0.68

2.3

1.9

—

Fracture of foot, except ankle

1.59

0.68

4.6

2.9

—

Overjet

1.64

0.67

7.0

5.4

—

Chronic diseases of tonsils and adenoids

235

1.24

0.67

3.0

2.9

—

Leiomyoma of uterus

1.63

0.67

1.4

1.1

—

Infections specific to the perinatal period

1.64

0.67

4.3

5.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

165

0.66

0.67

2.4

2.6

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.56

0.66

4.8

5.0

—

Kela-code for severe mental illness

0.54

0.66

2.4

1.6

—

Myocardial infarction, without ST-elevation

1.61

0.66

1.0

1.1

—

Postmenopausal bleeding

1.69

0.64

1.0

1.2

—

Congenital malformations of the respiratory system

1.73

0.64

8.8

5.3

—

Injuries to unspecified part of trunk, limb or body region

1.72

0.64

3.8

3.9

—

Focal epilepsy

1.47

0.63

2.4

4.9

—

Other strabismus

120

1.41

0.63

5.5

4.1

—

Other soft tissue disorders, not elsewhere classified

237

1.22

0.63

3.5

2.9

—

Myocardial infarction

1.54

0.62

1.5

1.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

102

0.59

0.62

1.0

3.3

—

Superficial injury of ankle and foot

1.63

0.62

2.3

3.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.59

0.61

1.8

1.3

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.61

0.0

4.4

—

Coxarthrosis, primary, with hip surgery

1.58

0.60

1.3

1.1

—

143

1.35

0.60

2.3

2.0

—

Unspecific neurodegenerative disorder

0.00

0.60

0.0

1.1

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.60

0.0

5.1

—

Disorders of vestibular function (Vertigo)

1.54

0.60

1.1

1.4

—

Diabetic retinopathy, excluding more controls

1.55

0.60

2.6

2.0

—

Injury, poisoning and certain other consequences of external causes

130

1.27

0.59

3.8

2.8

—

Inflammatory diseases of female pelvic organs

1.38

0.59

3.2

1.6

—

Depression or dysthymia

111

1.31

0.58

2.2

1.7

—

Stroke, excluding SAH

1.42

0.58

2.4

1.8

—

Malignant neoplasm of skin

1.51

0.58

1.0

1.3

—

Dental pulpitis 4

226

0.80

0.58

1.4

3.1

—

Coxarthrosis, primary

1.49

0.57

1.2

—

Basal cell carcinoma

1.56

0.56

1.0

1.2

—

Other juvenile arthritis

1.67

0.56

3.0

5.8

—

Psoriasis vulgaris

1.67

0.56

3.2

2.6

—

Polyp of the female genital tract

1.54

0.56

1.2

1.6

—

STROKE

1.36

0.56

2.2

1.7

—

Injuries to the neck

1.45

0.56

1.3

2.7

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.62

0.55

1.2

2.6

—

Glucosamine medication

1.53

0.55

1.1

—

Hypertensive heart and/or renal disease

1.60

0.55

5.5

1.8

—

Childhood allergy (age < 16)

145

1.31

0.55

2.2

4.9

—

Atrial fibrillation and flutter with reimbursement

1.60

0.55

1.3

1.4

—

Substance abuse, excluding more controls

116

1.36

0.55

2.6

1.5

—

Diseases of pulp and periapical tissues, including avohilmo

224

0.81

0.54

1.4

3.0

—

Dental pulpitis 1

224

0.81

0.54

1.4

3.0

—

Diseases of male genital organs

133

1.25

0.54

3.1

3.2

—

Insomnia

1.58

0.54

3.5

2.4

—

Dorsopathies

209

1.20

0.53

2.2

2.7

—

Cholecystectomy

118

1.35

0.53

1.6

1.5

—

Major coronary heart disease event excluding revascularizations

1.38

0.52

1.6

1.4

—

Type 1 diabetes, wide definition

0.62

0.52

3.8

4.2

—

Acne vulgaris

1.50

0.51

4.0

4.4

—

Basal cell carcinoma, including avohilmo

1.51

0.50

1.0

1.2

—

Non-selective monoamine reuptake inhibitors

1.39

0.50

1.1

—

Gonarthrosis [arthrosis of knee](FG)

0.70

0.50

1.1

—

Soft tissue disorders

248

1.17

0.50

3.2

3.0

—

Thyrotoxicosis

1.46

0.50

1.5

2.2

—

Open wound of head

209

0.75

0.48

2.6

3.2

—

Spondylosis

0.63

0.48

1.3

—

Other arthrosis

0.68

0.46

1.3

—

Other (not insulin) diabetes medications

148

0.77

0.46

1.5

1.4

—

Schizophrenia or delusion

0.60

0.45

1.6

1.8

—

Schizophrenia, schizotypal and delusional disorders

0.60

0.45

1.6

1.8

—

Intracranial trauma

182

0.78

0.45

3.7

2.9

—

Enthesopathies of lower limb, excluding foot

1.40

0.45

1.4

2.0

—

Keratitis

1.40

0.44

2.7

2.4

—

Other spirochaetal diseases

1.37

0.44

2.6

2.1

—

Other maternal disorders predominantly related to pregnancy

0.71

0.44

1.9

1.4

—

Carpal tunnel syndrome

118

0.69

0.43

1.4

1.2

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.61

0.43

2.4

4.3

—

Type 2 diabetes

146

1.22

0.43

1.9

1.5

—

Injuries to the head

299

0.85

0.42

3.2

2.9

—

Burns and corrosions

1.43

0.42

1.9

4.6

—

Alzheimer disease, excluding more controls

0.00

0.42

0.0

1.2

—

Spondylolisthesis/Spondylolysis

1.56

0.42

1.0

1.5

—

Other respiratory conditions originating in the perinatal period

0.00

0.42

0.0

5.4

—

Alzheimer disease, including avohilmo

0.00

0.42

0.0

1.1

—

Atopic dermatitis, strict definition

190

1.24

0.42

2.8

4.1

—

Use of anticholinesterases

0.00

0.41

0.0

1.1

—

N06DA Anticholinesterases

0.00

0.41

0.0

1.1

—

In situ neoplasms

1.54

0.41

2.0

1.2

—

Calcific aortic valvular stenosis, operated

1.53

0.41

1.2

2.1

—

Calcific aortic valvular stenosis

1.53

0.41

1.2

2.1

—

Disorders of synovium and tendon

134

1.28

0.41

3.6

1.7

—

Diabetic retinopathy

1.36

0.41

2.6

1.8

—

Personality disorders, excluding more controls

1.38

0.41

1.6

1.3

—

Stroke, including SAH

1.32

0.41

2.4

1.8

—

HSIL lesion of the cervix uteri, vagina or vulva

1.52

0.41

2.0

1.4

—

Hypertrophy of breast in women and men

1.52

0.41

1.4

1.9

—

Stenosis and insufficiency of lacrimal passages

0.00

0.41

0.0

3.5

—

Infections of genitourinary tract in pregnancy

0.00

0.41

0.0

1.5

—

Subarachnoid haemorrhage

0.00

0.41

0.0

2.6

—

Metatarsalgia

0.00

0.41

0.0

2.2

—

Disorders of muscles

0.00

0.41

0.0

2.4

—

Parkinson's disease, including avohilmo

0.00

0.41

0.0

1.2

—

Specific personality disorders

1.36

0.41

1.6

1.8

—

Contact with machinery

0.00

0.40

0.0

1.3

—

Cervicocranial syndrome

0.00

0.40

0.0

1.9

—

Abrasion of teeth

1.47

0.40

1.0

1.2

—

Pedal cyclist injured in noncollision transport accidents

1.47

0.40

2.0

4.2

—

Myocardial infarction, strict

1.43

0.40

1.6

1.3

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.40

0.0

6.2

—

Malignant neoplasm of bronchus and lung

0.00

0.40

0.0

1.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.35

0.40

2.5

2.9

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.40

0.0

2.1

—

Early lumbar disc prolapse operation

0.00

0.40

0.0

1.9

—

Superficial injury of hip and thigh

0.00

0.40

0.0

3.4

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.39

0.0

4.4

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.43

0.39

1.0

1.7

—

Thyrotoxicosis, other and/or unspecified

1.43

0.39

1.6

2.5

—

Pre-eclampsia

1.43

0.39

1.2

1.4

—

Unspecified mental disorder

106

0.66

0.39

2.0

1.6

—

Other chronic obstructive pulmonary disease, including avohilmo

1.39

0.39

1.0

1.3

—

Type 2 diabetes, definitions combined

138

1.21

0.38

1.4

1.3

—

Redundant prepuce, phimosis and paraphimosis

1.40

0.38

4.9

2.7

—

Panic disorder

1.39

0.38

2.4

2.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.39

0.38

1.2

1.9

—

Papulosquamous disorders

1.35

0.37

2.7

2.1

—

Alcohol use disorder, ICD-based

1.33

0.37

1.5

1.6

—

Chronic suppurative otitis media, including avohilmo

1.35

0.37

2.0

4.7

—

Medical treatment for female infertility

1.35

0.37

1.6

1.3

—

Unstable angina pectoris

1.46

0.36

1.0

1.1

—

Artificial joint operation, meniscal resection

142

0.80

0.36

1.1

1.5

—

Gestational [pregnancy-induced] hypertension

1.46

0.36

1.3

—

Constipation

234

1.16

0.36

2.8

3.2

—

Medical abortion

1.26

0.36

1.5

1.6

—

Maternal care for other conditions predominantly related to pregnancy

1.44

0.35

1.5

1.3

—

Dental caries 2, only avohilmo

253

0.84

0.35

3.6

2.7

—

Gestational diabetes (for exclusion)

1.39

0.35

1.4

1.6

—

Superficial injury of abdomen, lower back and pelvis

1.40

0.35

2.8

3.9

—

Non-allergic asthma

1.36

0.34

4.5

4.8

—

Other diseases of upper respiratory tract

244

1.13

0.34

3.1

2.9

—

Conotruncal defects

1.34

0.34

4.5

5.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.33

0.33

1.2

—

Dental caries 3

164

0.84

0.33

3.6

3.2

—

Other functional intestinal disorders

164

1.22

0.33

4.0

3.8

—

Retention of urine

1.30

0.33

1.0

1.9

—

Pure hypercholesterolaemia

1.24

0.32

1.2

1.8

—

Type 2 diabetes, strict (exclude DM1)

141

1.19

0.32

1.4

1.3

—

Fetus and newborn affected by maternal complications of pregnancy

1.28

0.32

5.3

5.7

—

Acetic acid derivatives and related substances

0.71

0.32

2.9

2.2

—

Asthma, including avohilmo

285

1.12

0.32

2.6

2.9

—

Other menopausal disorders

1.34

0.31

1.0

1.2

—

Long labour

1.36

0.31

1.1

1.3

—

Other disorders originating in the perinatal period

1.35

0.31

3.7

5.4

—

Type 1 diabetes

110

1.27

0.31

3.8

4.0

—

Obesity related asthma

1.33

0.30

1.3

2.1

—

Nonorganic sleeping disorders, excluding more controls

1.27

0.30

3.1

2.2

—

Irritable bowel syndrome

1.27

0.30

1.9

2.5

—

Type 1 diabetes, definitions combined

1.33

0.29

3.4

5.2

—

Ischaemic Stroke, excluding all haemorrhages

1.30

0.29

2.0

1.8

—

Injuries to the wrist and hand

274

0.87

0.29

2.6

2.8

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

108

0.74

0.29

2.4

3.2

—

Arthrosis

0.80

0.28

1.2

1.3

—

Superficial injury of lower leg

1.32

0.28

3.0

3.3

—

Other joint disorders

193

1.13

0.28

2.1

2.9

—

Personality disorders

1.21

0.26

1.6

1.8

—

Fracture of shoulder and upper arm

122

1.23

0.26

3.2

3.0

—

Poisoning by drugs, medicaments and biological substances

0.67

0.25

2.0

2.5

—

Obesity, other/unspecified

1.25

0.25

1.2

2.0

—

Obesity and other hyperalimentation

190

0.83

0.25

1.4

2.4

—

Obesity

190

0.83

0.25

1.4

2.4

—

Falls/tendency to fall

261

0.90

0.25

3.8

2.8

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.22

0.25

2.2

4.5

—

Glaucoma

1.29

0.24

2.7

1.6

—

Fracture of lower leg, including ankle

169

0.82

0.24

3.9

2.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

105

1.24

0.24

1.5

1.6

—

Effects of foreign body entering through natural orifice

1.25

0.24

3.6

3.4

—

Transport accidents

134

1.19

0.24

2.0

2.2

—

Cervical disc disorders

1.17

0.24

1.1

1.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.27

0.24

1.3

—

Primary gonarthrosis, bilateral

0.71

0.24

1.2

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.70

0.24

5.3

5.2

—

Fall on same level involving ice and snow

158

0.82

0.23

2.8

2.2

—

Triptan medication for migraine, min. 3 purchases

127

1.18

0.23

2.4

2.3

—

Mouth breathing

180

1.17

0.23

3.4

3.5

—

Migraine with aura and triptan purchases

1.32

0.23

2.0

3.3

—

Pre-eclampsia or eclampsia

1.32

0.23

1.2

1.4

—

Tinnitus

1.32

0.23

1.4

1.5

—

Sequelae of cerebrovascular disease

1.25

0.22

2.4

1.4

—

Injury of eye and orbit

1.25

0.22

2.4

3.2

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.22

0.0

1.1

—

Concussion

182

0.86

0.22

3.8

2.9

—

Ankyloglossia

1.22

0.22

4.2

5.9

—

Dysplasia of cervi uteri

1.21

0.22

2.0

1.3

—

Alzheimer disease

0.00

0.21

0.0

1.1

—

Other perinatal haematological disorders

0.00

0.21

0.0

6.4

—

Disorders of muscle tone of newborn

0.00

0.21

0.0

4.9

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

3.2

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

5.1

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Other congenital malformations of kidney

0.00

0.21

0.0

5.3

—

Hypospadias

0.00

0.21

0.0

5.2

—

Pollen allergy

144

0.82

0.21

1.8

4.5

—

Mesial bite

0.00

0.21

0.0

6.8

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

3.2

—

Foreign body or object entering through skin

0.00

0.21

0.0

2.2

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

2.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.6

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

1.2

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.6

—

Macular pucker

0.00

0.21

0.0

1.4

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.21

0.0

1.2

—

Other congenital malformations of ear

0.00

0.21

0.0

5.9

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.21

0.0

4.9

—

Traumatic subdural haemorrhage

0.00

0.21

0.0

1.8

—

Mental and behavioural disorders due to psychoactive substance use

154

1.16

0.21

2.5

1.9

—

Burns and corrosions of external body surface, specified by site

1.16

0.21

2.4

4.8

—

Substance use, excluding alcohol

1.16

0.21

1.0

1.9

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.2

—

Fall on and from ladder

0.00

0.21

0.0

2.2

—

Parkinson's disease

0.00

0.21

0.0

1.2

—

Parkinson's disease, excluding more controls

0.00

0.20

0.0

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

141

1.13

0.20

1.4

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

214

1.11

0.20

2.1

2.3

—

Pregnancy hypertension

1.25

0.20

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

157

0.87

0.20

2.0

2.2

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.8

—

Non-small cell lung cancer

0.00

0.20

0.0

1.2

—

Subjective visual disturbances

1.20

0.19

1.0

3.5

—

Type 2 diabetes, wide definition

119

1.15

0.19

1.8

1.3

—

Other neurological diseases

132

1.16

0.19

2.4

2.3

—

Peripheral artery disease

1.18

0.19

1.2

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

211

0.90

0.19

2.6

2.7

—

Dislocation, sprain and strain of joints and ligaments of knee

183

0.86

0.19

2.6

2.1

—

Lyme disease

1.18

0.19

2.8

2.1

—

Glaucoma suspect

1.18

0.19

3.8

1.5

—

Internal derangement of knee

1.21

0.19

1.6

2.2

—

Fracture at wrist and hand level

122

0.82

0.19

3.6

2.7

—

Mental retardation, excluding more controls

1.13

0.18

4.7

4.3

—

Fall on same level

279

1.08

0.18

3.0

2.9

—

Myalgia

1.13

0.18

1.7

2.0

—

Pre-eclampsia or poor fetal growth

1.13

0.18

1.2

1.3

—

Endometriosis

1.19

0.18

1.4

1.3

—

Nonorganic sleeping disorders

1.21

0.18

3.1

2.7

—

Injuries to the shoulder and upper arm

234

0.90

0.17

2.7

2.5

—

Hypothyroidism, strict autoimmune

116

1.14

0.17

2.0

2.8

—

False labour

0.71

0.17

1.6

1.7

—

Scissor bite

1.13

0.17

4.1

5.2

—

Allergic rhinitis

182

0.87

0.17

1.7

4.0

—

Schizophrenia or delusion, excluding more controls

0.72

0.16

1.6

1.3

—

Type 1 diabetes, strict (exclude DM2)

1.22

0.16

3.4

5.3

—

Diabetes mellitus in pregnancy

1.17

0.15

1.7

1.5

—

Pedal cyclist injured in transport accident

1.10

0.15

1.8

3.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

149

1.14

0.15

4.2

2.8

—

Mental and behavioural disorders due to alcohol

136

1.14

0.15

2.8

1.9

—

Disorders of vitreous body and globe

1.13

0.15

1.1

1.5

—

Deforming dorsopathies

1.11

0.15

2.4

2.9

—

Substance abuse

152

1.13

0.15

2.6

1.9

—

Lumbar disc prolapse

119

0.87

0.14

1.1

1.4

—

Diabetes medication

217

0.92

0.13

2.8

2.6

—

Nerve, nerve root and plexus disorders

167

1.09

0.13

2.1

1.6

—

Injuries to the elbow and forearm

241

1.09

0.13

3.4

2.9

—

D07AA Corticosteroids, weak (group I)

106

0.85

0.13

3.3

4.1

—

Other fall from one level to another

106

0.85

0.13

5.4

3.8

—

Obesity due to excess calories

138

0.87

0.13

1.6

2.7

—

Rotator cuff syndrome

105

1.13

0.13

1.1

1.2

—

Accidents

193

1.06

0.11

3.5

2.8

—

Disorders of the thyroid gland

195

1.07

0.10

1.8

2.5

—

Temporomandibular joint disorders, including avohilmo

115

1.13

0.10

1.5

2.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

193

1.09

0.09

4.3

3.2

—

Maternal care for other known or suspected fetal problems

1.07

0.09

1.2

1.7

—

Ganglion

1.06

0.09

3.4

1.6

—

All dysplastic lesions of the cervix uteri

1.06

0.09

2.0

1.3

—

Other and unspecified nonorganic psychotic disorders

1.04

0.09

1.6

2.3

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.11

0.09

4.3

5.8

—

Hypothyroidism, other/unspecified

177

0.93

0.09

2.0

2.5

—

Meniscus derangement

0.89

0.08

1.6

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.12

0.08

2.7

1.3

—

Symptoms and signs involving speech and voice

0.79

0.08

2.4

2.2

—

Extrapyramidal and movement disorders

0.79

0.08

1.0

2.1

—

Acute alcohol intoxication

0.78

0.08

5.4

2.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.08

0.08

2.0

1.6

—

Antenatal screening

1.04

0.08

1.4

1.8

—

Sleep disorders

1.06

0.08

3.1

2.7

—

Other disorders of eyelid

0.85

0.07

2.2

1.8

—

Mental retardation

0.82

0.07

4.7

5.5

—

Mental retardation, wide definition

0.82

0.07

4.7

5.5

—

Transient ischemic attack

1.09

0.07

1.1

1.4

—

Disorders of vitreous body

1.09

0.07

1.1

1.3

—

Pregnancy with abortive outcome

0.91

0.07

1.5

1.7

—

Sleep disorders (combined)

208

0.95

0.07

1.6

2.3

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.08

0.07

2.5

1.9

—

Hyperplasia of prostate

1.04

0.07

1.0

—

Unspecified fall

194

1.07

0.07

4.8

3.4

—

Diseases of appendix

187

1.07

0.07

1.6

1.7

—

Other symptoms and signs involving cognitive functions and awareness

1.06

0.07

1.0

2.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.86

0.07

2.0

—

Exposure to other specified factors

276

1.05

0.07

2.6

2.8

—

Dental caries 3 and operation codes

171

1.05

0.06

3.5

3.0

—

Other headache syndromes

104

0.87

0.06

1.8

2.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

187

1.05

0.05

2.5

2.3

—

Triptan medication for migraine, single purchase ok

187

1.05

0.05

2.5

2.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

198

0.96

0.05

2.6

2.7

—

Insulin, intermediate and long-acting

156

1.07

0.05

2.4

3.1

—

Other external causes of accidental injury

193

1.04

0.05

3.6

2.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

180

0.95

0.05

2.0

2.5

—

Sub-endpoint used in defining T1D endpoints

118

0.92

0.05

4.3

4.0

—

Benzodiazepine use

201

0.96

0.04

1.4

2.1

—

Gonarthrosis, primary, with knee surgery

1.10

0.04

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

140

0.93

0.04

5.6

3.5

—

Other intervertebral disc disorders

123

0.95

0.04

1.1

1.4

—

Vasomotor and allergic rhinitis

177

0.95

0.03

1.6

3.4

—

Injuries to the hip and thigh

102

1.08

0.03

2.8

3.0

—

Shoulder lesions

116

0.95

0.03

1.1

1.4

—

Fracture of forearm

170

1.05

0.02

3.9

2.9

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.08

0.02

1.9

1.3

—

Asthma/COPD (KELA code 203)

269

1.02

0.01

2.6

2.9

—

Striking against or struck by other objects

154

1.04

0.00

1.9

3.6

—

Injuries to the knee and lower leg

261

0.99

0.00

3.1

2.6

—

Selective serotonin reuptake inhibitors

181

1.02

0.00

2.1

2.4

—

Appendicitis, broad definition

187

1.03

0.00

1.3

1.7

—

Acute appendicitis, no complications

163

0.98

0.00

1.1

1.8

—

Sleep apnoea, including avohilmo

175

1.00

0.00

1.1

1.8

—

Sleep apnoea

167

1.02

0.00

1.1

1.8

—

Glucagon-like peptide-1 (GLP-1) analogues

1.04

0.00

1.5

1.3

—

Acute appendicitis

186

1.01

0.00

1.2

1.7

—

Fall on and from stairs and steps

1.00

0.00

1.5

3.4

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.3

—

Unspecified threat to breathing

0.00

0.0

5.7

—

Faecal incontinence

0.00

0.0

1.2

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.3

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.0

3.0

—

Testicular hypofunction

0.00

0.0

1.9

—

Lymphangioma, anys site

0.00

0.0

5.4

—

Prepatellar bursitis

0.00

0.0

2.5

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Other osteochondrodysplasias

0.00

0.0

4.8

—

Contact with other hot metals

0.00

0.0

5.2

—

Olecranon bursitis

0.00

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.0

1.3

—

Pleural plaque

0.00

0.0

1.0

—

Female infertility, tubal origin

0.00

0.0

1.3

—

Parkinson's disease, strict definition

0.00

0.0

1.2

—

Colon adenocarcinoma

0.00

0.0

1.3

—

L02BB Anti-androgens

0.00

0.0

1.0

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

0.0

4.4

—

Superficial injury of wrist and hand

0.98

0.00

2.9

3.6

—

Use of levodopa decarboxylase inhibitor

0.00

0.0

1.0

—

Tuberous sclerosis 1

0.00

0.0

3.8

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.4

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.00

0.0

5.2

—

In situ neoplasms

1.00

0.00

2.0

1.2

—

Osteogenesis imperfecta

0.00

0.0

5.6

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

0.00

0.0

2.5

—

Contact with nonpowered hand tool

0.00

0.0

1.6

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

5.3

—

Calcific tendinitis of shoulder

0.00

0.0

1.1

—

Use of memantine

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

1.01

0.00

1.0

1.6

—

Use of donepezil

0.00

0.0

1.0

—

Congenital malformations of oesophagus

0.00

0.0

5.2

—

Use of other anti-dementia drugs

0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Mastocytosis

0.00

0.0

5.0

—

Muscular dystrophy

0.00

0.0

7.3

—

Lactose intolerance

0.00

0.0

5.0

—

Microcephaly

0.00

0.0

5.5

—

Testicular dysfunction

0.00

0.0

1.9

—

Cluster headache, wide

0.00

0.0

1.8

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.0

2.5

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.0

2.0

—

Dementia in Alzheimer disease

0.00

0.0

1.0

—

Other surgical follow-up care

0.00

0.0

5.2

—

Ankylosing spondylitis, strict definition

0.00

0.0

1.4

—

Oral lichen ruber planus, including avohilmo

0.00

0.0

1.4

—

Congenital lens malformations

0.00

0.0

6.0

—

Down's syndrome

0.00

0.0

4.1

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.0

1.2

—

Failed induction of labour

0.00

0.0

1.5

—

Congenital malformations of genital organs

0.88

0.00

4.2

5.3

—

Alcohol-induced chronic pancreatitis

0.00

0.0

1.0

—

Dermatitis due to ingested food

0.93

0.00

3.2

5.0

—

Café au lait spots

0.00

0.0

4.9

—

Lung cancer and mesothelioma

0.00

0.0

1.0

—

Other abnormal products of conception

0.91

0.00

1.7

1.4

—

Congenital malformations of ear causing impairment of hearing

0.00

0.0

7.2

—

Disorder of visual pathways, unspecified

0.00

0.0

8.0

—

Unspecified event, undetermined intent

0.00

0.0

4.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.7

—

Unspecified visual impairment (binocular)

0.00

0.0

6.0

—

Other congenital malformations

1.01

0.00

3.4

5.1

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.0

3.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.4

—

Tetraplegia

0.00

0.0

3.2

—

Acute alcohol intoxication, ICD10

1.00

0.00

5.4

2.7

—

Communicating hydrocephalus

0.00

0.0

4.3

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.0

1.2

—

Transient global amnesia

0.00

0.0

1.3

—

Supervision of normal pregnancy

0.98

0.00

1.7

—

Congenital malformations of eye, ear, face and neck

1.00

0.00

4.8

5.7

—

Torticollis

0.00

0.0

7.0

—

Severe mental retardation

0.00

0.0

6.0

—

Disorders of adult personality and behaviour

0.99

0.00

1.6

2.2

—

Vasomotor rhinitis (mode)

0.00

0.0

1.3

—

Lactose intolerance, other/unspecified

0.00

0.0

5.0

—

Type1 diabetes, definitions combined, early onset

0.93

0.00

4.3

5.6

—

Hereditary retinal dystrophy

0.00

0.0

4.8

—

Alzheimer’s disease, wide definition

0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

0.0

1.2

—

Other demyelinating diseases of the central nervous system

0.00

0.0

3.8

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.0

1.5

—

Contusion of toe(s) without damage to nail

0.00

0.0

4.7

—

Suicide or other Intentional self-harm

0.90

0.00

2.2

—

Other specified and unspecified strabismus

0.00

0.0

3.7

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

2.3

—

Sequelae of injuries of head

0.00

0.0

1.5

—

Disorders of puberty, other/unspecified

0.00

0.0

4.6

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Convulsions of newborn

0.00

0.0

5.2

—

Birth injury to skeleton

0.00

0.0

6.6

—

Other and unspecified disorders of vitreous body

0.95

0.00

1.2

—

Digeorge syndrome

0.00

0.0

3.2

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.0

2.7

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

0.0

1.6

—

Immunodeficiency associated with other major defects

0.00

0.0

3.2

—

Supervision of high-risk pregnancy

0.98

0.00

1.6

1.7

—

Squamous cell neoplasms and carcinomas of the skin

0.00

0.0

1.0

—

Reduction defects of upper limb

0.00

0.0

4.4

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

5.0

—

Cleft hard palate NOS

0.00

0.0

6.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS